Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares (KNSA) is a publicly traded Healthcare sector company. As of May 21, 2026, KNSA trades at $54.28 with a market cap of $4.13B and a P/E ratio of 54.96. KNSA moved +1.84% today. Year to date, KNSA is +32.20%; over the trailing twelve months it is +103.30%. Its 52-week range spans $17.82 to $59.87. Analyst consensus is strong buy with an average price target of $64.00. Rallies surfaces KNSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
KNSA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. KNSA recently traded at $54.28. Market cap is $4.13B. P/E ratio is 54.96. Revenue is $754.04M.
| Metric | Value |
|---|---|
| Price | $54.28 |
| Market Cap | $4.13B |
| P/E Ratio | 54.96 |
| EPS | $0.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $59.87 |
| 52-Week Low | $17.82 |
| Volume | 14 |
| Avg Volume | 0 |
| Revenue (TTM) | $754.04M |
| Net Income | $73.06M |
| Gross Margin | 89.31% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $677.56M | $59.01M | $0.80 |
| 2024 | $423.24M | $-43.19M | $-0.60 |
| 2023 | $270.26M | $14.08M | $0.20 |
| 2022 | $220.18M | $183.36M | $2.64 |
7 analysts cover KNSA: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $64.00.